Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA... see more

TSX:MDP - Post Discussion

Medexus Pharmaceuticals Inc > Doubled up
View:
Post by GoldenArm on Jul 09, 2021 10:25am

Doubled up

Can't believe the lack of post here. This stock is a flyer in Q3 and Q4. My previous post outlines how one analyst has Medexus as their #1 holding. Do you DD and find out why this one has a potential to be over $20 by the end of 2021 and into 2022.
Comment by Boursicotte on Jul 19, 2021 4:14pm
Medexus Pharmaceuticals Inc. | MEDXF - $6.15 - OTCQX | Buy Stock Data 52-Week Low - High Shares Out. (mil) Mkt. Cap.(mil) 3-Mo. Avg. Vol. 12-Mo.Price Target Cash (mil) Tot. Debt (mil) Year ending March 31                    MEDXF: Treosulfan Could be a Game         $2.01 - $7.76 19.17 $117.89 18,095 We launch ...more  
Comment by Boursicotte on Jul 19, 2021 4:16pm
YES. $ 12 US 
Comment by Boursicotte on Jul 19, 2021 4:20pm
We launch coverage of Medexus Pharmaceuticals, Inc. with a Buy rating  a $12.00/share price target. 
Medexus Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities